SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NKTR Drug delivery Company
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
507 31 0 NKTR
Emcee:  david nordic Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
407There are certain tests a company is supposed to use to determine who is/isn'DewDiligence_on_SI-7/4/2018
406SVP (senior VP) usually is executive officer. Whatever,....early SVP-CMO was/isMiljenko Zuanic-7/3/2018
405Those two don't have to file on Form 4 b/c they are not Executive Officers oDewDiligence_on_SI-7/3/2018
404Question: Why Mary (CMO) and Jonathan (CSO) are not included in insiders stock-oMiljenko Zuanic-7/3/2018
40330.30+3.46 (+12.89%) Nektar (NKTR) Q3 Earnings & Sales Surpass, Sales View zax-11/8/2017
402 FDA Grants QIDP Designation to Bayer's Amikacin Inhale and CiproSavant-11/24/2014
401ncbi.nlm.nih.gov Recent AZN approval didn't accomplish much on the stock prArthur Radley-9/23/2014
400nejm.org Nice report in this respected medical journal, especially as we await Arthur Radley-6/4/2014
399seekingalpha.com Less than four weeks until we get some answers!Arthur Radley-5/22/2014
398Finally an event that has importance for those of us who have held NKTR for suchArthur Radley-5/13/2014
397 Nektar Reports Positive Preclinical Data for Two Oncology Programs aSavant-4/10/2014
396huffingtonpost.comArthur Radley-2/24/2014
395NKTR currently has 11 drugs(either directly controlled or partnered) in either PArthur Radley-1/16/2014
394seekingalpha.com Nice overview for NKTR.Arthur Radley-12/3/2013
393 Nektar Therapeutics reports on advancements with clinical pipeline aSavant-10/17/2013
392technologyreview.com Nice article in the MIT Review about the (NKTR) drug.Arthur Radley-9/2/2013
391latimes.com This is why I believe that NKTR is a good investment--that is if thArthur Radley-8/12/2013
390Motely Fool Article(6/26/13) Nektar Therapeutics (NASDAQ: NKTR) announced dataArthur Radley-6/27/2013
389I remember them talking about this at their R&D Day Event last year. Its cghmm-4/7/2013
388Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Arthur Radley14/7/2013
387Hit $10.99 this morning for new 52 week high--but volume is low, low, low!Arthur Radley-3/25/2013
386The replay is available now. I only heard parts of the presentation and didnghmm-3/22/2013
385Nice move in the stock today--got within a few pennies of breaking out above a nArthur Radley-3/21/2013
384seekingalpha.com Detailed article about the various programs that NKTR is involArthur Radley-3/21/2013
383Looks like we got that break above 9.50 :-). I didn't see any news and hearghmm-3/5/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News